Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Other Non Operating Income (2020 - 2025)

Biofrontera has reported Other Non Operating Income over the past 6 years, most recently at $373000.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at $373000.0 for Q4 2025, up 179.36% from a year ago — trailing twelve months through Dec 2025 was $40000.0 (up 104.93% YoY), and the annual figure for FY2025 was $40000.0, up 112.66%.
  • Other Non Operating Income for Q4 2025 was $373000.0 at Biofrontera, up from $30000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for BFRIW hit a ceiling of $373000.0 in Q4 2025 and a floor of -$470000.0 in Q4 2024.
  • Median Other Non Operating Income over the past 5 years was $14500.0 (2022), compared with a mean of -$6300.0.
  • Peak annual rise in Other Non Operating Income hit 259.09% in 2023, while the deepest fall reached 4766.67% in 2023.
  • Biofrontera's Other Non Operating Income stood at $270000.0 in 2021, then tumbled by 98.89% to $3000.0 in 2022, then plummeted by 4766.67% to -$140000.0 in 2023, then plummeted by 235.71% to -$470000.0 in 2024, then soared by 179.36% to $373000.0 in 2025.
  • The last three reported values for Other Non Operating Income were $373000.0 (Q4 2025), $30000.0 (Q3 2025), and -$264000.0 (Q2 2025) per Business Quant data.